We now accept payment from CareCredit, click here to Pay My Provider. To learn more about CareCredit contact us at 302-319-5680. As a safety precaution during peak flu season we are temporarily restricting visitors to age 16 or older at our Abby Medical Center and Christiana Hospital locations starting on Monday 2/19.
Delaware Center for Maternal & Fetal Medicine of Christiana Care, Inc.
Abby Medical Center Office: One Centurian Drive, Suite 312, Newark, DE 19713
Christiana Hospital: 4755 Ogletown-Stanton Road, Suite 1992,Newark, DE 19718
Phone: (302) 319-5680    Website: www.DCMFM.com
FOR OUR PATIENTS’ SAFETY DUE TO COVID-19
St Francis hospital is NOT allowing visitors or support people at this time

Abby Medical Center, Smyrna, Lewes and Christiana Care patients may have 1 visitor over the age of 16 accompany them to their appointment.

All patients and visitors must wear a mask.
All patients and visitors will be screened for illness at check-in.

If you have any of these symptoms: fever, cough, shortness of breath, sore throat, nausea, diarrhea or loss of taste or smell or have come in contact with someone who has COVID-19, please contact our office immediately at (302) 319-5680 to reschedule your appointment.

If you have results from COVID testing pending, you will be able to be seen in the office once negative results are received.


New patients must complete new patient paperwork prior to their appointment:
  • Pregnant patient paperwork - Click Here
  • Non-pregnant patient paperwork - Click Here
  • Or you may click on "FORMS" to print new patient paperwork

  • Please bring a valid photo ID and current insurance card at every visit. New patients should plan to arrive 15 minutes prior to their appointment time to check-in. All patients should be prepared to pay their copay at the time of service.
    After your appointment please visit us at: https://www.surveymonkey.com/r/MFMPatientSatisfactionSurvey to complete a brief survey about your experience. We appreciate your feedback!
    NIH Sponsored Research Studies
    Research Staff
    • Matthew Hoffman, MD Principle Investigator
    • Anthony Sciscione, DO Principle Investigator
    • Stephanie Lynch Research Nurse Manager
    • Research Nurse Coordinators
    • Colleen DeBosier | Jennifer Mann

    Our practice is involved in the following research studies. All of these studies are sponsored by the National Institute for Health:

    • A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
      Purpose - This study aims to screen pregnant women in the first half of pregnancy for recent primary CMV infection and evaluate in a proper randomized clinical trial whether maternal administration of CMV hyperimmune globulin will prevent congenital CMV infection. Qualifications - You must be less than 14 weeks pregnant and never given birth to a baby. Benefits - Participation may help doctors in the future find better treatments for mothers and babies. Participants will receive a modest compensation to reimburse them for time required to participate.
    • An Observational Study of Hepatitis C Virus in Pregnancy (HCV)
      Purpose - This observational study will allow a better understanding of HCV in pregnancy and will review the clinical and laboratory predictors of the risk of transmission to the fetus and newborn. Qualifications - Singleton pregnancy. Positive HCV antibody screen. Gestational age at screening no later than 23 weeks and 6 days and gestational age at enrollment no later than 27 weeks and 6 days. Benefits - Participation may help doctors in the future find better treatments for mothers and babies. Participants will receive a modest compensation to reimburse them for time required to participate.
    • ALPS
      The rate of pre-term birth has steadily increased in the US over the past 10 years. Late preterm infants experience a higher rate of readmission than their counterparts, and these infants are more likely to suffer complications such as respiratory distress, kernicterus, feeding difficulties, and hypoglycemia. The study is randomized, double masked, placebo-controlled clinical trial. This study would like to enroll 2800 women with singletons pregnancies who are likely to delivery between 34 0/7 and 36 0/7 weeks gestation nationwide. The purpose of the study is to evaluate whether antenatal corticosteroids can decrease the rate of neonatal respiratory support, thus decreasing NICU admissions for late preterm infants.

    Occasionally there are incentives for individuals to participate in research studies.  These incentives may be financial incentives or the incentive of having more ultrasounds (free of charge) than you would normally have during your pregnancy.  If you would like to find out if you qualify to participate in any of the research studies please contact the research coordinator:

    Stephanie Lynch
    Research Coordinator